Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), End user (Hospital, ASC) & Region Global Forecasts to 2029
The global ablation technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. Increasing risk for targeted diseases, supportive regulatory standards, and strategic partnerships and collaborations have driven demand for ablation technology market.
“The radiofrequency ablation segment of technology segment held the largest share of the market in 2023”
The ablation technology market is segmented based on technology into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed field ablation and hydrothermal/hydromechanical ablation. Increasing demand for cardiac and tumor ablation procedures, growing awareness for early diagnosis, and technological advancements contributes to the largest share for this segment.
“The consumable segment of product segment held the largest share of the market in 2023”
The ablation technology market is segmented based on product into systems and consumables. Large share of consumables segment is supported by rising adoption of ablation systems in the end user facilities. Consumables need to be replaced for each procedure ensuring the patient safety. Extended application areas such as aesthetics, pain management, recent technological advancements, and strict regulatory policies to ensuring patient safety contribute to the highest share of the segment.
“The cardiovascular disease treatment segment for application segment held the largest share of the market in 2023”.
Based on application, the ablation technology market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment and other applications. Cardiovascular disease treatment segment held largest share of the segment in 2023. Improved success rate of ablation treatment for CVD and emerging technologies in ablation drives the segment growth.
“The Ambulatory surgery centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The ablation technology market is segmented by end user into hospitals, surgical centers and ablation centers, ambulatory surgery centers, medical spas and aesthetic clinics & dermatology clinics, and other end users. The hospitals, surgical centers and ablation centers segment accounted for a significant market share in 2023. Improved insurance coverage and an increase in outpatient treatments are two major factors driving the expansion of the ambulatory surgery center segment.
“The market in the Asia pacific region is expected to witness the highest growth during the forecast period.”
Consistent rise in investment for healthcare services and infrastructure, especially in emerging economies, supports the rising installation of ablation systems. Key players in the market are focusing on expanding their presence in emerging countries to cater the increasing demand for ablation procedures. Moreover, the increasing number of hospitals, particularly in APAC region, increases the availability and accessibility of advanced treatment procedures, further driving the demand for ablation systems and consumables.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the ablation technology market based on technology, product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ablation technology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
“The radiofrequency ablation segment of technology segment held the largest share of the market in 2023”
The ablation technology market is segmented based on technology into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed field ablation and hydrothermal/hydromechanical ablation. Increasing demand for cardiac and tumor ablation procedures, growing awareness for early diagnosis, and technological advancements contributes to the largest share for this segment.
“The consumable segment of product segment held the largest share of the market in 2023”
The ablation technology market is segmented based on product into systems and consumables. Large share of consumables segment is supported by rising adoption of ablation systems in the end user facilities. Consumables need to be replaced for each procedure ensuring the patient safety. Extended application areas such as aesthetics, pain management, recent technological advancements, and strict regulatory policies to ensuring patient safety contribute to the highest share of the segment.
“The cardiovascular disease treatment segment for application segment held the largest share of the market in 2023”.
Based on application, the ablation technology market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment and other applications. Cardiovascular disease treatment segment held largest share of the segment in 2023. Improved success rate of ablation treatment for CVD and emerging technologies in ablation drives the segment growth.
“The Ambulatory surgery centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The ablation technology market is segmented by end user into hospitals, surgical centers and ablation centers, ambulatory surgery centers, medical spas and aesthetic clinics & dermatology clinics, and other end users. The hospitals, surgical centers and ablation centers segment accounted for a significant market share in 2023. Improved insurance coverage and an increase in outpatient treatments are two major factors driving the expansion of the ambulatory surgery center segment.
“The market in the Asia pacific region is expected to witness the highest growth during the forecast period.”
Consistent rise in investment for healthcare services and infrastructure, especially in emerging economies, supports the rising installation of ablation systems. Key players in the market are focusing on expanding their presence in emerging countries to cater the increasing demand for ablation procedures. Moreover, the increasing number of hospitals, particularly in APAC region, increases the availability and accessibility of advanced treatment procedures, further driving the demand for ablation systems and consumables.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
- By Designation: Director-level–10%, C-level–14%, and Others–76%
- By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%
Research Coverage
This report studies the ablation technology market based on technology, product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ablation technology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
- Analysis of key drivers (Emerging technologies in the field of ablation, increasing demand for minimally invasive procedures, favorable reimbursement scenario in developed markets, and growing target patient population), restraints (presence of strong alternative therapies, stringent regulatory system), opportunities (growth potential in emerging countries), and challenges (focus on reuse and reprocessing of devices, therapeutic challenges and hazardous effects of ablation) influencing the growth of the ablation technology market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the ablation technology market
- Market Development: Comprehensive information about lucrative markets–the report analyses the ablation technology market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players – such as Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US), AngioDynamics (US), CONMED corporation (US), Olympus (Japan) among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.4 STUDY SCOPE
1.4.1 SEGMENTS CONSIDERED
1.4.2 YEARS CONSIDERED
1.4.3 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key primary insights
2.1.2.4 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Customer-based market estimation
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
2.3 DATA TRIANGULATION
2.4 RESEARCH LIMITATIONS
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2024 VS. 2029 (USD MILLION)
4.3 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2024 VS. 2029 (USD MILLION)
4.4 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION)
4.5 GEOGRAPHIC SNAPSHOT OF ABLATION TECHNOLOGY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Emerging ablation technologies
5.2.1.2 Increasing demand for minimally invasive procedures
5.2.1.3 Growing target patient population
5.2.1.3.1 Rapid growth in geriatric population with higher risk of targeted diseases
5.2.1.3.2 Increasing incidence of cancer and sports injuries
5.2.1.3.3 Rising prevalence of atrial fibrillation and other cardiovascular diseases
5.2.1.4 Favorable reimbursement scenario in developed markets
5.2.2 RESTRAINTS
5.2.2.1 Strong market positioning of alternative therapies
5.2.2.2 Stringent regulatory systems
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Focus on reuse and reprocessing of devices
5.2.4.2 Therapeutic challenges and hazardous effects of ablation
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 MANUFACTURERS
5.4.1.1 Prominent companies
5.4.1.2 Small and medium-sized enterprises
5.4.2 END USERS
5.5 ECOSYSTEM ANALYSIS
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY ANALYSIS
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.3.1 Japan
5.6.1.3.2 China
5.6.1.3.3 India
5.6.1.4 Latin America
5.6.1.4.1 Brazil
5.6.2 REGULATORY APPROVALS
5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.3.1 North America
5.6.3.2 Europe
5.6.3.3 Asia Pacific
5.6.3.4 Latin America
5.6.3.5 Middle East & Africa
5.7 REIMBURSEMENT SCENARIO ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 PRICING ANALYSIS
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
5.10.2 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
5.11 PATENT ANALYSIS
5.11.1 TOP PATENT OWNERS/APPLICANTS
5.11.2 LIST OF MAJOR PATENTS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.15.1 RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
5.15.2 THERMOCOOL CATHETER CASE STUDY
5.16 TECHNOLOGY ANALYSIS
5.16.1 KEY TECHNOLOGIES
5.16.1.1 Thermal ablation technology
5.16.1.2 Non-thermal ablation technology
5.16.2 COMPLEMENTARY TECHNOLOGIES
5.16.2.1 Medical cooling systems
5.16.3 ADJACENT TECHNOLOGIES
5.16.3.1 Ablation planning software
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.18 UNMET NEEDS
5.19 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET
5.19.1 KEY USE CASES
6 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 RADIOFREQUENCY ABLATION
6.2.1 LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH
6.3 LASER/LIGHT ABLATION
6.3.1 LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH
6.4 ULTRASOUND ABLATION
6.4.1 HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH
6.5 ELECTRICAL ABLATION
6.5.1 INCREASING NUMBER OF CARDIAC ARRESTS TO BOOST ADOPTION
6.6 CRYOABLATION
6.6.1 FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET
6.7 MICROWAVE ABLATION
6.7.1 FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH
6.8 PULSED-FIELD ABLATION
6.8.1 IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH
6.9 HYDROTHERMAL/HYDROMECHANICAL ABLATION
6.9.1 INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA
TO AID MARKET GROWTH
7 ABLATION TECHNOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 RADIOFREQUENCY ABLATION SYSTEMS
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS
7.2.1.1 Technological advancements and improved clinical outcomes to propel segment growth
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS
7.2.2.1 Rising incidence of arrhythmia and growing focus on reducing collateral tissue damage to boost demand
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
7.2.3.1 Manual control of catheter movement and remote navigation to fuel segment
7.3 LASER/LIGHT ABLATION SYSTEMS
7.3.1 EXCIMER LASER ABLATION SYSTEMS
7.3.1.1 Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption
7.3.2 COLD LASER ABLATION SYSTEMS
7.3.2.1 Cold laser ablator treatment to release endorphins and support pain management
7.4 ULTRASOUND ABLATION SYSTEMS
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
7.4.1.1 Development of user-friendly surgical ablation systems to drive segment growth
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS
7.4.2.1 Low procedural time and reduced bleeding to support system adoption
7.4.3 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS
7.4.3.1 Growing incidence of obesity and diabetes to drive segment
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS
7.4.4.1 Non-pregnancy safe treatment procedure to limit adoption
7.5 ELECTRICAL ABLATION SYSTEMS
7.5.1 ARGON PLASMA/BEAM COAGULATION SYSTEMS
7.5.1.1 Increased focus on treating Barrett’s esophagus without dysplasia to augment segment growth
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS
7.5.2.1 Selective targeting and better control to aid segment growth
7.6 CRYOABLATION SYSTEMS
7.6.1 TECHNOLOGICAL ADVANCEMENTS AND INTRODUCTION OF NEW CRYOPROBES TO AID ADOPTION
7.6.2 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
7.7 MICROWAVE ABLATION SYSTEMS
7.7.1 PRODUCTION OF LARGE ABLATION ZONES WITHOUT HEAT-SINK EFFECT ON SURROUNDING TISSUES TO DRIVE MARKET
7.7.2 MICROWAVE THERMOTHERAPY SYSTEMS
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS
7.8.1 INCREASED NEED FOR MINIMALLY INVASIVE PROCEDURES FOR GYNECOLOGICAL DISORDERS TO SUPPORT MARKET GROWTH
7.8.2 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
7.9 CONSUMABLES
7.9.1 GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH
8 ABLATION TECHNOLOGY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIOVASCULAR DISEASE TREATMENT
8.2.1 INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH
8.3 CANCER TREATMENT
8.3.1 HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH
8.3.2 LIVER CANCER
8.3.3 KIDNEY CANCER
8.3.4 PROSTATE CANCER
8.3.5 LUNG CANCER
8.3.6 BONE METASTASIS
8.3.7 BREAST CANCER
8.4 ORTHOPEDIC TREATMENT
8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH
8.5 COSMETIC/AESTHETIC SURGERY
8.5.1 INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH
8.6 UROLOGICAL TREATMENT
8.6.1 HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET
8.7 GYNECOLOGICAL TREATMENT
8.7.1 INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH
8.8 PAIN MANAGEMENT
8.8.1 MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH
8.9 OPHTHALMOLOGICAL TREATMENT
8.9.1 RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH
8.10 OTHER APPLICATIONS
9 ABLATION TECHNOLOGY MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
9.2.1 HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
9.3 AMBULATORY SURGERY CENTERS
9.3.1 NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH
9.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS
9.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH
9.5 OTHER END USERS
10 ABLATION TECHNOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American ablation technology market during forecast period
10.2.3 CANADA
10.2.3.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth
10.3.3 FRANCE
10.3.3.1 Growing geriatric population and rising prevalence of cancer to aid market growth
10.3.4 UK
10.3.4.1 Rising target patient population and growing awareness about advanced treatment options to drive market
10.3.5 ITALY
10.3.5.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth
10.3.6 SPAIN
10.3.6.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Presence of universal healthcare reimbursement system to augment market growth
10.4.3 CHINA
10.4.3.1 Increased patient pool and favorable government initiatives to fuel market growth
10.4.4 INDIA
10.4.4.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth
10.4.5 AUSTRALIA
10.4.5.1 Increased research investments and favorable government initiatives to spur market growth
10.4.6 SOUTH KOREA
10.4.6.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Increasing government funding and growing burden of chronic diseases to propel market growth
10.5.3 MEXICO
10.5.3.1 Availability of advanced care initiatives and awareness programs to fuel market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH PUBLIC-PRIVATE INVESTMENTS TO STIMULATE MARKET GROWTH
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Technology footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 JOHNSON & JOHNSON
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product approvals
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 BOSTON SCIENTIFIC CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product approvals
12.1.3.3.2 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices made
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 ABBOTT
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product approvals
12.1.4.3.2 Deals
12.1.5 ATRICURE, INC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.6 ANGIODYNAMICS
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 CONMED CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 OLYMPUS CORPORATION
12.1.8.1 Products offered
12.1.8.2 Recent developments
12.1.8.2.1 Product launches
12.1.8.2.2 Deals
12.1.9 VARIAN MEDICAL SYSTEMS, INC.
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.9.3.2 Deals
12.1.10 SMITH+NEPHEW
12.1.10.1 Business overview
12.1.10.2 Product offered
12.1.10.3 Recent developments
12.1.10.3.1 Expansions
12.1.11 STRYKER
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Product approvals
12.1.11.3.2 Expansions
12.1.12 CYNOSURE LUTRONIC
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.13 BIOVENTUS
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.2.1 Deals
12.1.14 MERIT MEDICAL SYSTEMS
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 CANYON MEDICAL INC.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 ARTHREX, INC.
12.2.2 ICECURE MEDICAL
12.2.3 MINIMAX MEDICAL HOLDING GROUP
12.2.4 CARDIOFOCUS
12.2.5 EDAP TMS
12.2.6 MERMAID MEDICAL
12.2.7 MONTERIS
12.2.8 SONABLATE CORP.
12.2.9 ECO MEDICAL
12.2.10 SURGNOVA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS
TABLE 3 ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT
TABLE 4 ESTIMATED GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 (IN MILLION)
TABLE 5 CPT CODES FOR REIMBURSEMENT OF ABLATION TECHNOLOGIES
TABLE 6 ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION
TABLE 7 ABLATION TECHNOLOGY MARKET: ROLE IN ECOSYSTEM
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 10 US: CLASSIFICATION OF ABLATION DEVICES
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 14 REGULATORY APPROVALS REQUIRED FOR ABLATION DEVICES, BY COUNTRY
TABLE 15 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MEDICAL REIMBURSEMENT CODES FOR CRYOABLATION PROCEDURAL SERVICES IN US (2024)
TABLE 21 MEDICAL REIMBURSEMENT CODES FOR ABLATION TECHNOLOGY IN US,
2021–2024
TABLE 22 INDICATIVE SELLING PRICE OF ABLATION SYSTEMS, BY REGION,
2021–2023 (USD)
TABLE 23 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 24 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 25 LIST OF MAJOR PATENTS IN ABLATION TECHNOLOGY MARKET,
JANUARY 2022–MARCH 2024
TABLE 26 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES
TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 28 INFLUENCE OF KEY END USERS ON BUYING PROCESS
TABLE 29 KEY BUYING CRITERIA FOR END USERS
TABLE 30 ABLATION TECHNOLOGY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 31 CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
TABLE 32 CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY
TABLE 33 THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
TABLE 34 NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
TABLE 35 ABLATION TECHNOLOGY MARKET: INTENSITY OF CURRENT UNMET NEEDS
TABLE 36 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 37 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 38 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 39 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 40 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 41 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 42 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 43 PULSED-FIELD ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 44 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 45 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 46 ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 48 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 49 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 50 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 52 LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 53 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 55 COLD LASER ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 56 ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 58 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 59 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 60 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 61 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62 ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 63 ELECTRICAL ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 64 ARGON PLASMA/BEAM COAGULATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 65 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 CRYOABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 67 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 68 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 69 ABLATION TECHNOLOGY CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 70 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT,
BY REGION, 2022–2029 (USD MILLION)
TABLE 72 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION,
2022–2029 (USD MILLION)
TABLE 73 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,
BY REGION, 2022–2029 (USD MILLION)
TABLE 75 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 76 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION,
2022–2029 (USD MILLION)
TABLE 78 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,
BY REGION, 2022–2029 (USD MILLION)
TABLE 79 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2029 (USD MILLION)
TABLE 80 ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 81 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2022–2029 (USD MILLION)
TABLE 83 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 84 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION,
2022–2029 (USD MILLION)
TABLE 85 ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: KEY MACROINDICATORS
TABLE 97 US: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 98 CANADA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 99 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 100 EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 101 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 102 EUROPE: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 103 EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 104 EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 105 EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 106 EUROPE: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 107 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 108 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 109 EUROPE: KEY MACROINDICATORS
TABLE 110 GERMANY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 111 FRANCE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 112 UK: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 113 ITALY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 114 SPAIN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 115 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 121 ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 ASIA PACIFIC: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 124 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 126 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 127 JAPAN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 128 CHINA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 129 INDIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 130 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 131 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 132 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 138 LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 139 LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 140 LATIN AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 141 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: KEY MACROINDICATORS
TABLE 144 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 145 MEXICO: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 146 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: ELECTRICAL ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
TABLE 158 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
TABLE 159 ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT
TABLE 160 ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 161 ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT
TABLE 162 ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT
TABLE 163 ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT
TABLE 164 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 165 ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 166 ABLATION TECHNOLOGY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2024
TABLE 167 ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–JULY 2024
TABLE 168 ABLATION TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
TABLE 169 JOHNSON & JOHNSON: COMPANY OVERVIEW
TABLE 170 JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 171 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 172 JOHNSON & JOHNSON: DEALS, JANUARY 2021?JULY 2024
TABLE 173 MEDTRONIC: COMPANY OVERVIEW
TABLE 174 MEDTRONIC: PRODUCTS OFFERED
TABLE 175 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 176 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 177 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 178 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2021?JULY 2024
TABLE 179 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021?JULY 2024
TABLE 180 ABBOTT: COMPANY OVERVIEW
TABLE 181 ABBOTT: PRODUCTS OFFERED
TABLE 182 ABBOTT: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 183 ABBOTT: DEALS, JANUARY 2021?JULY 2024
TABLE 184 ATRICURE, INC.: COMPANY OVERVIEW
TABLE 185 ATRICURE, INC.: PRODUCTS OFFERED
TABLE 186 ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021?JULY 2024
TABLE 187 ANGIODYNAMICS: COMPANY OVERVIEW
TABLE 188 ANGIODYNAMICS: PRODUCTS OFFERED
TABLE 189 ANGIODYNAMICS: DEALS, JANUARY 2021?JULY 2024
TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW
TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 192 OLYMPUS CORPORATION: COMPANY OVERVIEW
TABLE 193 OLYMPUS CORPORATION: PRODUCTS OFFERED
TABLE 194 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021?JULY 2024
TABLE 195 OLYMPUS CORPORATION: DEALS, JANUARY 2021?JULY 2024
TABLE 196 VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 197 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 198 VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES,
JANUARY 2021?JULY 2024
TABLE 199 VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021?JULY 2024
TABLE 200 SMITH+NEPHEW: COMPANY OVERVIEW
TABLE 201 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 202 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021?JULY 2024
TABLE 203 STRYKER: COMPANY OVERVIEW
TABLE 204 STRYKER: PRODUCTS OFFERED
TABLE 205 STRYKER: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 206 STRYKER: EXPANSIONS, JANUARY 2021?JULY 2024
TABLE 207 CYNOSURE LUTRONIC: COMPANY OVERVIEW
TABLE 208 CYNOSURE LUTRONIC: PRODUCTS OFFERED
TABLE 209 CYNOSURE LUTRONIC: DEALS, JANUARY 2021?JULY 2024
TABLE 210 BIOVENTUS: COMPANY OVERVIEW
TABLE 211 BIOVENTUS: PRODUCTS OFFERED
TABLE 212 BIOVENTUS: DEALS, JANUARY 2021?JULY 2024
TABLE 213 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 214 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 215 CANYON MEDICAL INC.: COMPANY OVERVIEW
TABLE 216 CANYON MEDICAL INC.: PRODUCTS OFFERED
TABLE 217 ARTHREX, INC.: COMPANY OVERVIEW
TABLE 218 ICECURE MEDICAL: COMPANY OVERVIEW
TABLE 219 MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW
TABLE 220 CARDIOFOCUS: COMPANY OVERVIEW
TABLE 221 EDAP TMS: COMPANY OVERVIEW
TABLE 222 MERMAID MEDICAL: COMPANY OVERVIEW
TABLE 223 MONTERIS: COMPANY OVERVIEW
TABLE 224 SONABLATE CORP.: COMPANY OVERVIEW
TABLE 225 ECO MEDICAL: COMPANY OVERVIEW
TABLE 226 SURGNOVA: COMPANY OVERVIEW
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.4 STUDY SCOPE
1.4.1 SEGMENTS CONSIDERED
1.4.2 YEARS CONSIDERED
1.4.3 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key primary insights
2.1.2.4 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Customer-based market estimation
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
2.3 DATA TRIANGULATION
2.4 RESEARCH LIMITATIONS
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2024 VS. 2029 (USD MILLION)
4.3 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2024 VS. 2029 (USD MILLION)
4.4 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION)
4.5 GEOGRAPHIC SNAPSHOT OF ABLATION TECHNOLOGY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Emerging ablation technologies
5.2.1.2 Increasing demand for minimally invasive procedures
5.2.1.3 Growing target patient population
5.2.1.3.1 Rapid growth in geriatric population with higher risk of targeted diseases
5.2.1.3.2 Increasing incidence of cancer and sports injuries
5.2.1.3.3 Rising prevalence of atrial fibrillation and other cardiovascular diseases
5.2.1.4 Favorable reimbursement scenario in developed markets
5.2.2 RESTRAINTS
5.2.2.1 Strong market positioning of alternative therapies
5.2.2.2 Stringent regulatory systems
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Focus on reuse and reprocessing of devices
5.2.4.2 Therapeutic challenges and hazardous effects of ablation
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 MANUFACTURERS
5.4.1.1 Prominent companies
5.4.1.2 Small and medium-sized enterprises
5.4.2 END USERS
5.5 ECOSYSTEM ANALYSIS
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY ANALYSIS
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.3.1 Japan
5.6.1.3.2 China
5.6.1.3.3 India
5.6.1.4 Latin America
5.6.1.4.1 Brazil
5.6.2 REGULATORY APPROVALS
5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.3.1 North America
5.6.3.2 Europe
5.6.3.3 Asia Pacific
5.6.3.4 Latin America
5.6.3.5 Middle East & Africa
5.7 REIMBURSEMENT SCENARIO ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 PRICING ANALYSIS
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
5.10.2 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
5.11 PATENT ANALYSIS
5.11.1 TOP PATENT OWNERS/APPLICANTS
5.11.2 LIST OF MAJOR PATENTS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.15.1 RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
5.15.2 THERMOCOOL CATHETER CASE STUDY
5.16 TECHNOLOGY ANALYSIS
5.16.1 KEY TECHNOLOGIES
5.16.1.1 Thermal ablation technology
5.16.1.2 Non-thermal ablation technology
5.16.2 COMPLEMENTARY TECHNOLOGIES
5.16.2.1 Medical cooling systems
5.16.3 ADJACENT TECHNOLOGIES
5.16.3.1 Ablation planning software
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.18 UNMET NEEDS
5.19 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET
5.19.1 KEY USE CASES
6 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 RADIOFREQUENCY ABLATION
6.2.1 LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH
6.3 LASER/LIGHT ABLATION
6.3.1 LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH
6.4 ULTRASOUND ABLATION
6.4.1 HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH
6.5 ELECTRICAL ABLATION
6.5.1 INCREASING NUMBER OF CARDIAC ARRESTS TO BOOST ADOPTION
6.6 CRYOABLATION
6.6.1 FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET
6.7 MICROWAVE ABLATION
6.7.1 FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH
6.8 PULSED-FIELD ABLATION
6.8.1 IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH
6.9 HYDROTHERMAL/HYDROMECHANICAL ABLATION
6.9.1 INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA
TO AID MARKET GROWTH
7 ABLATION TECHNOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 RADIOFREQUENCY ABLATION SYSTEMS
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS
7.2.1.1 Technological advancements and improved clinical outcomes to propel segment growth
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS
7.2.2.1 Rising incidence of arrhythmia and growing focus on reducing collateral tissue damage to boost demand
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
7.2.3.1 Manual control of catheter movement and remote navigation to fuel segment
7.3 LASER/LIGHT ABLATION SYSTEMS
7.3.1 EXCIMER LASER ABLATION SYSTEMS
7.3.1.1 Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption
7.3.2 COLD LASER ABLATION SYSTEMS
7.3.2.1 Cold laser ablator treatment to release endorphins and support pain management
7.4 ULTRASOUND ABLATION SYSTEMS
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
7.4.1.1 Development of user-friendly surgical ablation systems to drive segment growth
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS
7.4.2.1 Low procedural time and reduced bleeding to support system adoption
7.4.3 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS
7.4.3.1 Growing incidence of obesity and diabetes to drive segment
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS
7.4.4.1 Non-pregnancy safe treatment procedure to limit adoption
7.5 ELECTRICAL ABLATION SYSTEMS
7.5.1 ARGON PLASMA/BEAM COAGULATION SYSTEMS
7.5.1.1 Increased focus on treating Barrett’s esophagus without dysplasia to augment segment growth
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS
7.5.2.1 Selective targeting and better control to aid segment growth
7.6 CRYOABLATION SYSTEMS
7.6.1 TECHNOLOGICAL ADVANCEMENTS AND INTRODUCTION OF NEW CRYOPROBES TO AID ADOPTION
7.6.2 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
7.7 MICROWAVE ABLATION SYSTEMS
7.7.1 PRODUCTION OF LARGE ABLATION ZONES WITHOUT HEAT-SINK EFFECT ON SURROUNDING TISSUES TO DRIVE MARKET
7.7.2 MICROWAVE THERMOTHERAPY SYSTEMS
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS
7.8.1 INCREASED NEED FOR MINIMALLY INVASIVE PROCEDURES FOR GYNECOLOGICAL DISORDERS TO SUPPORT MARKET GROWTH
7.8.2 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
7.9 CONSUMABLES
7.9.1 GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH
8 ABLATION TECHNOLOGY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 CARDIOVASCULAR DISEASE TREATMENT
8.2.1 INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH
8.3 CANCER TREATMENT
8.3.1 HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH
8.3.2 LIVER CANCER
8.3.3 KIDNEY CANCER
8.3.4 PROSTATE CANCER
8.3.5 LUNG CANCER
8.3.6 BONE METASTASIS
8.3.7 BREAST CANCER
8.4 ORTHOPEDIC TREATMENT
8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH
8.5 COSMETIC/AESTHETIC SURGERY
8.5.1 INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH
8.6 UROLOGICAL TREATMENT
8.6.1 HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET
8.7 GYNECOLOGICAL TREATMENT
8.7.1 INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH
8.8 PAIN MANAGEMENT
8.8.1 MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH
8.9 OPHTHALMOLOGICAL TREATMENT
8.9.1 RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH
8.10 OTHER APPLICATIONS
9 ABLATION TECHNOLOGY MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
9.2.1 HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
9.3 AMBULATORY SURGERY CENTERS
9.3.1 NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH
9.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS
9.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH
9.5 OTHER END USERS
10 ABLATION TECHNOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American ablation technology market during forecast period
10.2.3 CANADA
10.2.3.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth
10.3.3 FRANCE
10.3.3.1 Growing geriatric population and rising prevalence of cancer to aid market growth
10.3.4 UK
10.3.4.1 Rising target patient population and growing awareness about advanced treatment options to drive market
10.3.5 ITALY
10.3.5.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth
10.3.6 SPAIN
10.3.6.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Presence of universal healthcare reimbursement system to augment market growth
10.4.3 CHINA
10.4.3.1 Increased patient pool and favorable government initiatives to fuel market growth
10.4.4 INDIA
10.4.4.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth
10.4.5 AUSTRALIA
10.4.5.1 Increased research investments and favorable government initiatives to spur market growth
10.4.6 SOUTH KOREA
10.4.6.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Increasing government funding and growing burden of chronic diseases to propel market growth
10.5.3 MEXICO
10.5.3.1 Availability of advanced care initiatives and awareness programs to fuel market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH PUBLIC-PRIVATE INVESTMENTS TO STIMULATE MARKET GROWTH
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Technology footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 JOHNSON & JOHNSON
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product approvals
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 BOSTON SCIENTIFIC CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product approvals
12.1.3.3.2 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices made
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 ABBOTT
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product approvals
12.1.4.3.2 Deals
12.1.5 ATRICURE, INC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.6 ANGIODYNAMICS
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 CONMED CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 OLYMPUS CORPORATION
12.1.8.1 Products offered
12.1.8.2 Recent developments
12.1.8.2.1 Product launches
12.1.8.2.2 Deals
12.1.9 VARIAN MEDICAL SYSTEMS, INC.
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.9.3.2 Deals
12.1.10 SMITH+NEPHEW
12.1.10.1 Business overview
12.1.10.2 Product offered
12.1.10.3 Recent developments
12.1.10.3.1 Expansions
12.1.11 STRYKER
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Product approvals
12.1.11.3.2 Expansions
12.1.12 CYNOSURE LUTRONIC
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.13 BIOVENTUS
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.2.1 Deals
12.1.14 MERIT MEDICAL SYSTEMS
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 CANYON MEDICAL INC.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 ARTHREX, INC.
12.2.2 ICECURE MEDICAL
12.2.3 MINIMAX MEDICAL HOLDING GROUP
12.2.4 CARDIOFOCUS
12.2.5 EDAP TMS
12.2.6 MERMAID MEDICAL
12.2.7 MONTERIS
12.2.8 SONABLATE CORP.
12.2.9 ECO MEDICAL
12.2.10 SURGNOVA
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS
TABLE 3 ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT
TABLE 4 ESTIMATED GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 (IN MILLION)
TABLE 5 CPT CODES FOR REIMBURSEMENT OF ABLATION TECHNOLOGIES
TABLE 6 ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION
TABLE 7 ABLATION TECHNOLOGY MARKET: ROLE IN ECOSYSTEM
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 10 US: CLASSIFICATION OF ABLATION DEVICES
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 14 REGULATORY APPROVALS REQUIRED FOR ABLATION DEVICES, BY COUNTRY
TABLE 15 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MEDICAL REIMBURSEMENT CODES FOR CRYOABLATION PROCEDURAL SERVICES IN US (2024)
TABLE 21 MEDICAL REIMBURSEMENT CODES FOR ABLATION TECHNOLOGY IN US,
2021–2024
TABLE 22 INDICATIVE SELLING PRICE OF ABLATION SYSTEMS, BY REGION,
2021–2023 (USD)
TABLE 23 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 24 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 25 LIST OF MAJOR PATENTS IN ABLATION TECHNOLOGY MARKET,
JANUARY 2022–MARCH 2024
TABLE 26 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES
TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 28 INFLUENCE OF KEY END USERS ON BUYING PROCESS
TABLE 29 KEY BUYING CRITERIA FOR END USERS
TABLE 30 ABLATION TECHNOLOGY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 31 CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
TABLE 32 CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY
TABLE 33 THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
TABLE 34 NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING
TABLE 35 ABLATION TECHNOLOGY MARKET: INTENSITY OF CURRENT UNMET NEEDS
TABLE 36 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 37 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 38 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 39 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 40 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 41 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 42 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 43 PULSED-FIELD ABLATION TECHNOLOGY MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 44 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 45 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 46 ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 48 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 49 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 50 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 52 LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 53 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 55 COLD LASER ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 56 ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 58 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 59 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 60 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 61 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62 ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 63 ELECTRICAL ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 64 ARGON PLASMA/BEAM COAGULATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 65 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 CRYOABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 67 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 68 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 69 ABLATION TECHNOLOGY CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 70 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT,
BY REGION, 2022–2029 (USD MILLION)
TABLE 72 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION,
2022–2029 (USD MILLION)
TABLE 73 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,
BY REGION, 2022–2029 (USD MILLION)
TABLE 75 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 76 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION,
2022–2029 (USD MILLION)
TABLE 78 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,
BY REGION, 2022–2029 (USD MILLION)
TABLE 79 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2029 (USD MILLION)
TABLE 80 ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 81 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2022–2029 (USD MILLION)
TABLE 83 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 84 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION,
2022–2029 (USD MILLION)
TABLE 85 ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: KEY MACROINDICATORS
TABLE 97 US: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 98 CANADA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 99 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 100 EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 101 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 102 EUROPE: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 103 EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 104 EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 105 EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 106 EUROPE: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 107 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 108 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 109 EUROPE: KEY MACROINDICATORS
TABLE 110 GERMANY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 111 FRANCE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 112 UK: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 113 ITALY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 114 SPAIN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 115 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 121 ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 ASIA PACIFIC: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 124 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 126 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 127 JAPAN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 128 CHINA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 129 INDIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 130 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 131 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 132 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 133 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 138 LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 139 LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 140 LATIN AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 141 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: KEY MACROINDICATORS
TABLE 144 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 145 MEXICO: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,
2022–2029 (USD MILLION)
TABLE 146 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2022–2029 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: ELECTRICAL ABLATION SYSTEMS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
TABLE 158 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
TABLE 159 ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT
TABLE 160 ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 161 ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT
TABLE 162 ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT
TABLE 163 ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT
TABLE 164 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 165 ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 166 ABLATION TECHNOLOGY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2024
TABLE 167 ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–JULY 2024
TABLE 168 ABLATION TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
TABLE 169 JOHNSON & JOHNSON: COMPANY OVERVIEW
TABLE 170 JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 171 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 172 JOHNSON & JOHNSON: DEALS, JANUARY 2021?JULY 2024
TABLE 173 MEDTRONIC: COMPANY OVERVIEW
TABLE 174 MEDTRONIC: PRODUCTS OFFERED
TABLE 175 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 176 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 177 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 178 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2021?JULY 2024
TABLE 179 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021?JULY 2024
TABLE 180 ABBOTT: COMPANY OVERVIEW
TABLE 181 ABBOTT: PRODUCTS OFFERED
TABLE 182 ABBOTT: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 183 ABBOTT: DEALS, JANUARY 2021?JULY 2024
TABLE 184 ATRICURE, INC.: COMPANY OVERVIEW
TABLE 185 ATRICURE, INC.: PRODUCTS OFFERED
TABLE 186 ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021?JULY 2024
TABLE 187 ANGIODYNAMICS: COMPANY OVERVIEW
TABLE 188 ANGIODYNAMICS: PRODUCTS OFFERED
TABLE 189 ANGIODYNAMICS: DEALS, JANUARY 2021?JULY 2024
TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW
TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 192 OLYMPUS CORPORATION: COMPANY OVERVIEW
TABLE 193 OLYMPUS CORPORATION: PRODUCTS OFFERED
TABLE 194 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021?JULY 2024
TABLE 195 OLYMPUS CORPORATION: DEALS, JANUARY 2021?JULY 2024
TABLE 196 VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 197 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 198 VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES,
JANUARY 2021?JULY 2024
TABLE 199 VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021?JULY 2024
TABLE 200 SMITH+NEPHEW: COMPANY OVERVIEW
TABLE 201 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 202 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021?JULY 2024
TABLE 203 STRYKER: COMPANY OVERVIEW
TABLE 204 STRYKER: PRODUCTS OFFERED
TABLE 205 STRYKER: PRODUCT APPROVALS, JANUARY 2021?JULY 2024
TABLE 206 STRYKER: EXPANSIONS, JANUARY 2021?JULY 2024
TABLE 207 CYNOSURE LUTRONIC: COMPANY OVERVIEW
TABLE 208 CYNOSURE LUTRONIC: PRODUCTS OFFERED
TABLE 209 CYNOSURE LUTRONIC: DEALS, JANUARY 2021?JULY 2024
TABLE 210 BIOVENTUS: COMPANY OVERVIEW
TABLE 211 BIOVENTUS: PRODUCTS OFFERED
TABLE 212 BIOVENTUS: DEALS, JANUARY 2021?JULY 2024
TABLE 213 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 214 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 215 CANYON MEDICAL INC.: COMPANY OVERVIEW
TABLE 216 CANYON MEDICAL INC.: PRODUCTS OFFERED
TABLE 217 ARTHREX, INC.: COMPANY OVERVIEW
TABLE 218 ICECURE MEDICAL: COMPANY OVERVIEW
TABLE 219 MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW
TABLE 220 CARDIOFOCUS: COMPANY OVERVIEW
TABLE 221 EDAP TMS: COMPANY OVERVIEW
TABLE 222 MERMAID MEDICAL: COMPANY OVERVIEW
TABLE 223 MONTERIS: COMPANY OVERVIEW
TABLE 224 SONABLATE CORP.: COMPANY OVERVIEW
TABLE 225 ECO MEDICAL: COMPANY OVERVIEW
TABLE 226 SURGNOVA: COMPANY OVERVIEW
